SARCNU
SARCNU Uses, Dosage, Side Effects, Food Interaction and all others data.
SARCNU has been used in trials studying the treatment of Colorectal Cancer, Brain and Central Nervous System Tumors, and Unspecified Adult Solid Tumor, Protocol Specific.
| Trade Name | SARCNU |
| Generic | 2-chloroethyl-3-sarcosinamide-1-nitrosourea |
| 2-chloroethyl-3-sarcosinamide-1-nitrosourea Other Names | SARCNU, Sarmustine |
| Type | |
| Formula | C6H11ClN4O3 |
| Weight | Average: 222.63 Monoisotopic: 222.0519679 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SARCNU
